Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
RESEARCH TOOLSreports
AFT Pharmaceuticals Ltd. (AFP) Share Price & Analysis
2 Followers
AFP Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$2.50 - AU$3.69
Previous CloseAU$2.85
Volume0.00
Average Volume (3M)1.21K
Market Cap
AU$299.09M
Enterprise ValueAU$328.84M
Total Cash (Recent Filing)$7.94M
Total Debt (Recent Filing)$40.51M
Price to Earnings (P/E)29.5
Beta0.16
Next Earnings
May 22, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)0.10
Shares OutstandingN/A
10 Day Avg. Volume34,422
30 Day Avg. Volume1,206
Standard Deviation0.10
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.80Price Target Upside― Upside
Rating ConsensusModerate Sell
Number of Analyst Covering1
AFT Pharmaceuticals Ltd. News
PremiumCompany Announcements
AFT Pharmaceuticals Innovates Scar Treatment SolutionsOptions Prices
Currently, No data available
---
Ownership Overview
70.33% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
29.67% Public Companies and
Individual Investors
AFP FAQ
What was AFT Pharmaceuticals Ltd.’s price range in the past 12 months?
AFT Pharmaceuticals Ltd. lowest share price was AU$2.50 and its highest was AU$3.69 in the past 12 months.
What is AFT Pharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is AFT Pharmaceuticals Ltd.’s upcoming earnings report date?
AFT Pharmaceuticals Ltd.’s upcoming earnings report date is May 22, 2024 which is in 25 days.
How were AFT Pharmaceuticals Ltd.’s earnings last quarter?
AFT Pharmaceuticals Ltd. released its earnings results on Nov 22, 2023. The company reported AU$0.016 earnings per share for the quarter, missing the consensus estimate of AU$0.027 by -AU$0.011.
Is AFT Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts AFT Pharmaceuticals Ltd.’s price is currently Undervalued.
Does AFT Pharmaceuticals Ltd. pay dividends?
AFT Pharmaceuticals Ltd. does not currently pay dividends.
What is AFT Pharmaceuticals Ltd.’s EPS estimate?
AFT Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AFT Pharmaceuticals Ltd. have?
AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding.
What happened to AFT Pharmaceuticals Ltd.’s price movement after its last earnings report?
AFT Pharmaceuticals Ltd. reported an EPS of AU$0.016 in its last earnings report, missing expectations of AU$0.027. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AFT Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:AFP
---
AFT Pharmaceuticals Ltd. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
16.87%
Trailing 12-Months
Asset Growth
33.11%
Trailing 12-Months
Company Description
AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Coco-scalp, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Southeast Asia and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.
---
AFP Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering AFP
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-8.30%
downgraded a sell rating 2 months ago
Copying Christian Bell's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -8.30% per trade.
---